Antibiotic resistance is a moving target, and even the most successful drugs eventually lose their edge. Around the turn of ...

If you ask the commissioner of the US Food and Drug Administration about the greatest hurdles to treating disease in the US, he doesn’t point to any of the scientific problems his agency is working on ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Healthcare generates an unprecedented amount of data from electronic health records, medical imaging, genomics, and more. This data, when effectively harnessed, is proving to be key to unlocking ...

Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

La Trobe scientists have made a pivotal discovery in the fight against dangerous drug-resistant bacteria, as the University ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

The US Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.

Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...

Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico ...